Chargement en cours...
Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds.
In a double-blind, placebo-controlled study, patients with naturally occurring common colds of less than or equal to 48 h duration were randomly assigned to receive nasal sprays of recombinant alfa-2b interferon at 10 or 20 MU/day or placebo four times per day for 5 days. The 10-MU (n = 74), 20-MU (...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
1988
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC172139/ https://ncbi.nlm.nih.gov/pubmed/2834996 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|